Literature DB >> 15939855

Unit-dose packaging of iron supplements and reduction of iron poisoning in young children.

Milton Tenenbein1.   

Abstract

BACKGROUND: Iron poisoning is a major cause of unintentional poisoning death in young children. The US Food and Drug Administration proclaimed a regulation for unit-dose packaging of iron supplements in 1997.
OBJECTIVE: To determine whether the requirement for unit-dose packaging of iron supplements decreases the incidence of iron ingestion and the incidence of deaths due to iron poisoning in children younger than 6 years.
METHODS: This is a preintervention-postintervention study of the US federally mandated requirement for unit-dose packaging of iron supplements. The 10 years prior to the intervention were compared with the 5 years after its promulgation. The incidences of iron ingestion and of iron poisoning deaths for children younger than 6 years were obtained from the annual reports of the American Association of Poison Control Centers (Washington, DC).
RESULTS: The average number of iron ingestion calls per 1000 of all calls to poison control centers regarding children younger than 6 years decreased from 2.99 per 1000 to 1.91 per 1000 (odds ratio, 1.29 [95% confidence interval, 1.27-1.32]; P<.001). The number of deaths decreased from 29 to 1 (odds ratio, 13.56 [95% confidence interval, 1.85-99.52]; P = .03).
CONCLUSIONS: These are the first data that show a decrease in the incidence of nonintentional ingestion of a specific drug by young children and a decrease in mortality from poisoning by this drug after the introduction of unit-dose packaging. There was a decrease in the incidence of iron ingestion and a dramatic decrease in the number of deaths due to iron poisoning. This validates unit-dose packaging as an effective strategy for the prevention of iron poisoning and iron poisoning deaths in young children. This highly effective intervention should be considered for other medications with a high hazard for morbidity and mortality when taken as an overdose.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939855     DOI: 10.1001/archpedi.159.6.557

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  9 in total

1.  Impact of the voluntary withdrawal of over-the-counter cough and cold medications on pediatric ingestions reported to poison centers.

Authors:  Wendy Klein-Schwartz; John David Sorkin; Suzanne Doyon
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-08       Impact factor: 2.890

2.  Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products.

Authors:  David Goldberger; David Vearrier
Journal:  J Med Toxicol       Date:  2017-07-14

3.  Suicidal antidepressant overdoses: a comparative analysis by antidepressant type.

Authors:  Nicole White; Toby Litovitz; Cathleen Clancy
Journal:  J Med Toxicol       Date:  2008-12

4.  Preventing unintentional injuries in the home using the Health Impact Pyramid.

Authors:  Karin A Mack; Karen D Liller; Grant Baldwin; David Sleet
Journal:  Health Educ Behav       Date:  2015-04

5.  The Role of Unit-Dose Child-Resistant Packaging in Unintentional Childhood Exposures to Buprenorphine-Naloxone Tablets.

Authors:  Christian Hampp; Maribeth C Lovegrove; Daniel S Budnitz; Justin Mathew; Amy Ho; Jana McAninch
Journal:  Drug Saf       Date:  2020-02       Impact factor: 5.606

6.  An examination of product packaging marketing strategies used to promote pediatric multivitamins.

Authors:  Danna Ethan; Corey H Basch; Lalitha Samuel; Christine Quinn; Stephanie Dunne
Journal:  J Community Health       Date:  2015-06

Review 7.  Medication-associated gastrointestinal tract injury.

Authors:  Michael Vieth; Elizabeth Montgomery
Journal:  Virchows Arch       Date:  2017-01-30       Impact factor: 4.535

8.  An examination of marketing techniques used to promote children's vitamins in parenting magazines.

Authors:  Corey Hannah Basch; Katherine J Roberts; Danna Ethan; Sandra Samayoa-Kozlowsky
Journal:  Glob J Health Sci       Date:  2014-11-26

9.  Chelation of Thallium (III) in Rats Using Combined Deferasirox and Deferiprone Therapy.

Authors:  Samie Salehi; Amir Sh Saljooghi; Somayeh Badiee; Mojtaba Mashmool Moqadam
Journal:  Toxicol Res       Date:  2015-10-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.